Schedule 13G ownership disclosure

ARIAD PHARMACEUTICALS INC

Security class unavailable · CUSIP: 04033A100

Event date: 2016-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,957,058
Percent of class
2.5500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-17-000429
Form type
SC 13G/A
Filer
ARIAD PHARMACEUTICALS INC
CIK
CIK 884731
Filed
Feb 10, 2017
Reporting period
Dec 30, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub